EW Stock Summary and Trading Ideas (Edwards Lifesciences | NYSE:EW)

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Edwards Lifesciences trades on the NYSE stock market under the symbol EW.

As of October 23, 2026, EW stock price declined to $89.07 with 2,416,833 million shares trading.

EW has a beta of 0.60, meaning it tends to be less sensitive to market movements. EW has a correlation of 0.09 to the broad based SPY ETF.

EW has a market cap of $51.34 billion. This is considered a Large Cap stock.

Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.78 earnings per share. This beat revenue expectation by $41 million and exceeded earnings estimates by $.04.

In the last 3 years, EW traded as high as $96.29 and as low as $58.93.

The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

EW has outperformed the market in the last year with a price return of +15.9% while the SPY ETF gained +14.9%. EW has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +5.6% and +5.7%, respectively, while the SPY returned +1.9% and -1.8%, respectively.

EW support price is $88.77 and resistance is $91.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW shares will trade within this expected range on the day.